Published in Blood Weekly, May 2nd, 2002
"Defined angiographically, no-reflow (NR) manifests as an acute reduction in coronary flow in the absence of epicardial vessel obstruction," explained Dr. Diana Bonderman and colleagues at the Mount Sinai School of Medicine in New York City, the University of Vienna, and the Ludwig Boltzmann Institute for Cardiovascular Research and the Institute for Molecular Oncology in Vienna, Austria. "One candidate protein to cause coronary NR is tissue factor (TF), which is abundant in atherosclerotic plaque and a cofactor for activated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2002-05-02)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.